DrugPatentWatch Database Preview
ANJESO Drug Profile
Email this page to a colleague
» See Plans and PricingWhich patents cover Anjeso, and what generic alternatives are available?
Anjeso is a drug marketed by Baudax and is included in one NDA. There are four patents protecting this drug.
This drug has thirty patent family members in eleven countries.
The generic ingredient in ANJESO is meloxicam. There are twenty-two drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the meloxicam profile page.
US ANDA Litigation and Generic Entry Outlook for Anjeso
A generic version of ANJESO was approved as meloxicam by BRECKENRIDGE PHARM on July 19th, 2006.
Summary for ANJESO
| International Patents: | 30 |
| US Patents: | 4 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ANJESO |
| DailyMed Link: | ANJESO at DailyMed |
US Patents and Regulatory Information for ANJESO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baudax | ANJESO | meloxicam | SOLUTION;INTRAVENOUS | 210583-001 | Feb 20, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Baudax | ANJESO | meloxicam | SOLUTION;INTRAVENOUS | 210583-001 | Feb 20, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Baudax | ANJESO | meloxicam | SOLUTION;INTRAVENOUS | 210583-001 | Feb 20, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Baudax | ANJESO | meloxicam | SOLUTION;INTRAVENOUS | 210583-001 | Feb 20, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Baudax | ANJESO | meloxicam | SOLUTION;INTRAVENOUS | 210583-001 | Feb 20, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ANJESO
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2012012397 | Start Trial |
| Germany | 602004021107 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2005002542 | Start Trial |
| Japan | 2011042670 | Start Trial |
| Japan | 2016053028 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
